Related Experiment Videos
Is there a place for liver grafting for malignancy?
1Klinik für Abdominal-und Transplantationschirurgie, Medizinische Hochschule, Hannover, FRG.
Transplantation Proceedings
|February 1, 1988
Summary
Liver transplantation for liver cancer offers potential but has disappointing long-term results due to tumor recurrence. Patient selection and tumor stage are critical for successful outcomes in hepatic transplantation.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Transplantation Medicine
Background:
- Liver transplantation is a treatment option for unresectable liver tumors.
- Previous studies show limited long-term success due to high tumor recurrence rates.
Purpose of the Study:
- To evaluate the long-term outcomes of liver transplantation for malignant liver tumors.
- To identify factors influencing survival and determine patient selection criteria.
Main Methods:
- Retrospective analysis of 94 liver transplantations performed between 1972 and 1987 for malignant liver tumors.
- Evaluation of tumor type, stage, lymph node status, and survival rates.
- Calculation of actuarial survival data for different tumor types and stages.
Main Results:
- Overall long-term results were disappointing, with tumor recurrence being common.
- Hepatocellular carcinoma (HCC) without cirrhosis and bile duct tumors in lymph node-negative stages showed better survival rates.
- Lymph node-positive stages demonstrated significantly worse survival outcomes across all tumor types.
Conclusions:
- Careful patient selection is paramount for improving outcomes in liver transplantation for cancer.
- Hepatic transplantation can be justified for selected tumor patients, necessitating further analysis of tumor-specific success rates.
- Tumor stage, particularly lymph node status, is a more critical prognostic factor than tumor type.